Dornase
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 436 publications
Characterizing Bronchoscopy in Pediatric Critical Care: A Cohort Analysis of Practice and Outcomes.
Journal: Journal of intensive care medicine
Published: April 09, 2026
2026 Clinical Practice Guideline Update by the Infectious Diseases Society of America and the Pediatric Infectious Diseases Society on The Management of Community-acquired Pneumonia in Infants and Children Older than 3 Months of Age: The Use of tPa and DNase or tPa Alone for Fibrinolysis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 27, 2026
Infusion of tPA-dornase for management of intraabdominal abscesses: a case report.
Journal: Journal of surgical case reports
Published: December 07, 2025
Transitioning paediatric empyema management: Comparative efficacy analysis of tPA and DNase versus surgical interventions.
Journal: Journal of pediatric surgery
Published: October 18, 2025
Therapeutic potential of a long-acting form of rhDNase I for the treatment of cystic fibrosis.
Journal: International journal of biological macromolecules
Published: October 16, 2025
The impact of dornase alfa on imaging features of bronchiectasis.
Journal: Research square
Published: September 15, 2025
Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 01, 2025
Pharmaceutical Compatibility of Tissue Plasminogen Activator and DNase.
Journal: Respiration; international review of thoracic diseases
Published: July 25, 2025
Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients.
Journal: Pulmonary pharmacology & therapeutics
Published: June 27, 2025
Last Updated: 04/28/2026